TUP1-mediated filamentation in Candida albicans leads to inability to colonize the mouse gut

Future Microbiology

Volumn 13, Issue 8, 2018, Pages 857-867

  Román, Elvira ^a   Huertas, Blanca ^a   Prieto, Daniel ^a   Díez Orejas, Rosalía ^a   Pla, Jesús ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Candida albicans; commensalism; filamentous growth; TUP1

Indexed keywords

BILE SALT; TETRACYCLINE DERIVATIVE; FUNGAL PROTEIN;

ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FEMALE; FUNGAL COLONIZATION; FUNGAL GENE; FUNGUS GROWTH; GENE EXPRESSION; IN VIVO STUDY; INTESTINE; INTESTINE EPITHELIUM; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUP1 GENE; ANIMAL; C57BL MOUSE; CANDIDIASIS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIOLOGY;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; FEMALE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; INTESTINES; MICE; MICE, INBRED C57BL;

EID: 85049408923     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb-2018-0012     Document Type: Article

References (36)

1. Navarro-García F, Sánchez M, Nombela C, Pla J. Virulence genes in the pathogenic yeast Candida albicans. FEMS Microbiol. Rev. 25(2), 245-268 (2001).
2. Berman J, Sudbery PE. Candida albicans: a molecular revolution built on lessons from budding yeast. Nat. Rev. Genet. 3(12), 918-930 (2002).
3. Perez-Nadales E, Nogueira MF, Baldin C et al. Fungal model systems and the elucidation of pathogenicity determinants. Fungal Genet. Biol. 70, 42-67 (2014).
4. Naglik JR, Fidel PL, Jr., Odds FC. Animal models of mucosal Candida infection. FEMS Microbiol. Lett. 283(2), 129-139 (2008).
5. Kinneberg KM, Bendel CM, Jechorek RP et al. Effect of INT1 gene on Candida albicans murine intestinal colonization. J. Surg. Res. 87(2), 245-251 (1999).
6. Bendel CM, Wiesner SM, Garni RM, Cebelinski E, Wells CL. Cecal colonization and systemic spread of Candida albicans in mice treated with antibiotics and dexamethasone. Pediatr. Res. 51(3), 290-295 (2002).
7. Koh AY, Kohler JR, Coggshall KT, Van RN, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog. 4(2), e35 (2008).
8. Koh AY. Murine models of Candida gastrointestinal colonization and dissemination. Eukaryot. Cell 12(11), 1416-1422 (2013).
9. Prieto D, Correia I, Pla J, Roman E. Adaptation of Candida albicans to commensalism in the gut. Future Microbiol. 11, 567-583 (2016).
10. Neville BA, D'Enfert C, Bougnoux ME. Candida albicans commensalism in the gastrointestinal tract. FEMS Yeast Res. 15(7), 1-13 (2015).
11. Noble SM, Gianetti BA, Witchley JN. Candida albicans cell-type switching and functional plasticity in the mammalian host. Nat. Rev. Microbiol. 15(2), 96-108 (2016).
12. Noble SM. Candida albicans specializations for iron homeostasis: from commensalism to virulence. Curr. Opin. Microbiol. 16(6), 708-715 (2013).
13. Prieto AD, Román E, Correia I, Pla J. The HOG pathway is critical for the colonization of the mouse gastrointestinal tract by Candida albicans. PLoS ONE 9(1), e87128 (2014).
14. Perez JC, Kumamoto CA, Johnson AD. Candida albicans commensalism and pathogenicity are intertwined traits directed by a tightly knit transcriptional regulatory circuit. PLoS Biol. 11(3), e1001510 (2013).
15. Lo HJ, Kohler JR, Didomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous Candida albicans mutants are avirulent. Cell 90(5), 939-949 (1997).
16. Alonso-Monge R, Navarro-García F, Molero G et al. Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicans. J. Bacteriol. 181(10), 3058-3068 (1999).
17. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot. Cell 2(5), 1053-1060 (2003).
18. Saville SP, Lazzell AL, Chaturvedi AK, Monteagudo C, Lopez-Ribot JL. Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice. Infect. Immun. 76(1), 97-102 (2008).
19. Vautier S, Drummond RA, Chen K et al. Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity. Cell. Microbiol. 17(4), 445-450 (2015).
20. Prieto D, Pla J. Distinct stages during colonization of the mouse gastrointestinal tract by Candida albicans. Front. Microbiol. 6, 792 (2015).
21. Braun BR, Johnson AD. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277(5322), 105-109 (1997).
22. Miranda LN, Van Der Heijden IM, Costa SF et al. Candida colonisation as a source for candidaemia. J. Hosp. Infect. 72(1), 9-16 (2009).
23. Correia I, Roman E, Prieto D, Eisman B, Pla J. Complementary roles of the Cek1 and Cek2 MAP kinases in Candida albicans cell-wall biogenesis. Future Microbiol. 11, 51-67 (2016).
24. Urrialde V, Prieto D, Pla J, Alonso-Monge R. The Pho4 transcription factor mediates the response to arsenate and arsenite in Candida albicans. Front. Microbiol. 6, 118 (2015).
25. Román E, Nombela C, Pla J. The Sho1 adaptor protein links oxidative stress to morphogenesis and cell wall biosynthesis in the fungal pathogen Candida albicans. Mol. Cell. Biol. 25(23), 10611-10627 (2005).
26. Bochner BR, Huang HC, Schieven GL, Ames BN. Positive selection for loss of tetracycline resistance. J. Bacteriol. 143(2), 926-933 (1980).
27. Kobayashi GS, Cutler JE. Candida albicans hyphal formation and virulence: is there a clearly defined role? Trends Microbiol. 6(3), 92-94 (1998).
28. Mitchell AP. Dimorphism and virulence in Candida albicans. Curr. Opin. Microbiol. 1(6), 687-692 (1998).
29. Liu H. Co-regulation of pathogenesis with dimorphism and phenotypic switching in Candida albicans, a commensal and a pathogen. Int. J. Med. Microbiol. 292(5-6), 299-311 (2002).
30. Jacobsen ID, Wilson D, Wachtler B, Brunke S, Naglik JR, Hube B. Candida albicans dimorphism as a therapeutic target. Expert Rev. Anti Infect. Ther. 10(1), 85-93 (2012).
31. Saville SP, Lazzell AL, Bryant AP et al. Inhibition of filamentation can be used to treat disseminated candidiasis. Antimicrob. Agents Chemother. 50(10), 3312-3316 (2006).
32. Odds FC, Davidson AD, Jacobsen MD et al. Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. J. Clin. Microbiol. 44(10), 3647-3658 (2006).
33. Park YN, Morschhauser J. Tetracycline-inducible gene expression and gene deletion in Candida albicans. Eukaryot. Cell 4(8), 1328-1342 (2005).
34. Prieto D, Roman E, Alonso-Monge R, Pla J. Overexpression of the transcriptional regulator WOR1 increases susceptibility to bile salts and adhesion to the mouse gut mucosa in Candida albicans. Front. Cell. Infect. Microbiol. 7, 389 (2017).
35. Kadosh D, Johnson AD. Induction of the Candida albicans filamentous growth program by relief of transcriptional repression: a genome-wide analysis. Mol. Biol. Cell 16(6), 2903-2912 (2005).
36. Krysan DJ, Böhm L, Torsin S et al. The yeast form of the fungus Candida albicans promotes persistence in the gut of gnotobiotic mice. PLoS Path. 13(10), (2017).